Forex ForexLive · Oct 15, 03:24 AM
Data due at the bottom of the hour, 0030 GMT / 2030 US Eastern time: unemployment seen at 4.6% Australia jobs preview: NAB sees 20,000 gain, unemployment steady at 4.6% This article was written by Eamonn Sheridan at investinglive.com.
Investing.com · Oct 15, 03:18 AM
YouTube explores audiobook feature for 2027 launch- WSJ
Investing.com · Oct 15, 03:16 AM
C3.ai CFO Hitesh Lath sells $247,399 in company stock
Investing.com · Oct 15, 02:54 AM
Trump says he hopes Pope Leo will ’get better fast’
Investing.com · Oct 15, 02:46 AM
BX Buzz ML-1 GP LLC sells $9.78m of Bumble (BMBL) stock
Investing.com · Oct 15, 02:46 AM
Palvella Therapeutics director George M. Jenkins disposes of $3.58m PVLA stock
Investing.com · Oct 15, 02:46 AM
Blackstone Holdings III GP management sells $9.79m of Bumble stock
Stock MarketWatch · Oct 15, 02:36 AM
Investors are wondering if steep inflation and increased borrowing costs could derail the AI buildout.
Investing.com · Oct 15, 02:35 AM
New ERA Energy & Digital director Kent McCarthy buys $1.19m in shares
Investing.com · Oct 15, 02:31 AM
BTOA-NQ LLC, Bumble 10% owner, sells $9.79m in stock
Investing.com · Oct 15, 02:30 AM
BCP Buzz Holdings L.P. sells $9.79 million in Bumble Inc. shares
Investing.com · Oct 15, 02:30 AM
BX Buzz ML-1 Holdco L.P. sells $9.79m Bumble stock
Investing.com · Oct 15, 02:06 AM
TSMC expected to report sixth straight quarter of record profit thanks to AI boom
Investing.com · Oct 15, 02:05 AM
Iambic Therapeutics prices IPO at $16 per share on Nasdaq
Investing.com · Oct 15, 02:04 AM
IBM survey finds 80% of EMEA firms report AI incidents to board
Investing.com · Oct 15, 02:01 AM
Wayfair director Steven Conine disposes of $7.3M in Class A shares
Investing.com · Oct 15, 02:01 AM
Xometry CEO Sanjeev Singh sells $163,201 in company stock
Investing.com · Oct 15, 02:01 AM
MediaAlpha director Eugene Nonko sells $236,973 in stock
Investing.com · Oct 15, 02:01 AM
Codexis CFO Georgia Erbez sells $8,619 of common stock
Investing.com · Oct 15, 01:56 AM
Iambic Therapeutics prices IPO at $16 per share
News text belongs to its source; only the headline and a short summary appear here.